Related Experiment Video
Updated: May 29, 2025
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Decision Aid for Pediatric Atopic Dermatitis
Anna B Fishbein1, Karen Kaiser2, Sarah B Welch3
1Department of Pediatrics, Division of Pediatric Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital, Chicago, Ill.
Insights
A new decision aid helps guide treatment choices for pediatric atopic dermatitis. This tool supports shared decision-making between patients, families, and clinicians, improving engagement in managing eczema.
Area of Science:
- Dermatology
- Health Informatics
- Patient-Centered Care
Background:
- Atopic dermatitis (eczema) is a chronic skin condition requiring complex care.
- Limited resources exist to aid patients, families, and clinicians in treatment decisions.
- Existing therapeutic options for eczema are expanding.
Purpose of the Study:
- To develop an evidence-based decision aid for pediatric atopic dermatitis.
- To ensure wide acceptance for shared decision-making in eczema management.
- To create a tool supporting patient and family engagement.
Main Methods:
- Conducted literature reviews and focus groups with patients/caregivers (n=32).
- Performed expert interviews (n=9) on shared decision-making strategies.
- Developed and pilot-tested a decision aid prototype through cognitive interviews (n=10) and clinic testing.
Main Results:
- Identified patient/parent preferences and expert-recommended implementation strategies.
- Systematically created a decision aid incorporating literature, focus group, and interview data.
- Clinic testing showed the tool was helpful (average score 7.8 ± 1.7).
Conclusions:
- A validated decision aid for pediatric atopic dermatitis can enhance clinical encounters.
- The tool promotes patient and family engagement in treatment decision-making.
- Future studies will assess the efficacy of this decision aid across diverse populations.
Background:
Atopic dermatitis is a common chronic skin disease that involves frequent physician visits and often complex care plans. Despite the expanding therapeutic options, there is no existing decision aid to guide patients, families, and clinicians through treatment options.
Objective:
Our objective was to develop an evidence-based decision aid that would be widely accepted for shared decision-making in pediatric atopic dermatitis.
Methods:
Per rigorous International Patient Decision Aid Standards, the following steps were taken: (1) literature review; (2) focus groups with patients and caregivers; (3) expert interviews; (4) prototype creation, revision, and pilot testing in the clinic; and (5) further in-clinic testing.
Results:
Six focus groups provided insight into patient/parent preferences (n = 32) regarding treatment experiences and preferences. Nine expert interviews revealed implementation strategies for shared decision-making, eliciting themes of communication, patient education, challenges to and supports for treatment adherence, useful materials/resources, and other strategies for success. Using content from literature review, patient/parent focus groups, and expert interviews, a draft decision aid was systematically created. Cognitive interviews (n = 10) with patients/parents resulted in tool refinement. In-clinic testing demonstrated that the tool was helpful; an average ± standard deviation score was 7.8 ± 1.7 (0-10 scale, n = 18). A final decision aid was produced.
Conclusions:
A decision aid for children with atopic dermatitis can be used for clinical encounters and has the potential to improve patient/family engagement in decision-making. In addition, we include a worksheet on patient/parent values and an eczema action plan for implementation. Efficacy of this tool will be tested across populations in future studies.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:30Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...